NDC 70868-750

LORTUSS LQ

Doxylamine Succinate, Pseudoephedrine Hydrochloride

LORTUSS LQ is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Key Therapeutics. The primary component is Doxylamine Succinate; Pseudoephedrine Hydrochloride.

Product ID70868-750_288f937b-e5f4-4a5c-83b9-165e1d5ad276
NDC70868-750
Product TypeHuman Otc Drug
Proprietary NameLORTUSS LQ
Generic NameDoxylamine Succinate, Pseudoephedrine Hydrochloride
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date2020-05-15
Marketing CategoryOTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
Application Numberpart341
Labeler NameKey Therapeutics
Substance NameDOXYLAMINE SUCCINATE; PSEUDOEPHEDRINE HYDROCHLORIDE
Active Ingredient Strength6 mg/5mL; mg/5mL
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 70868-750-16

473 mL in 1 BOTTLE (70868-750-16)
Marketing Start Date2020-05-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70868-750-16 [70868075016]

LORTUSS LQ LIQUID
Marketing CategoryOTC MONOGRAPH FINAL
Application Numberpart341
Product TypeHUMAN OTC DRUG
Marketing Start Date2020-05-15

Drug Details

NDC Crossover Matching brand name "LORTUSS LQ" or generic name "Doxylamine Succinate, Pseudoephedrine Hydrochloride"

NDCBrand NameGeneric Name
69036-110LORTUSS LQDoxylamine Succinate, Pseudoephedrine Hydrochloride
70868-750LORTUSS LQDoxylamine Succinate, Pseudoephedrine Hydrochloride
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.